Northwest Biotherapeutics (NWBO) Capital Expenditures (QoQ) (2011 - 2026)
Northwest Biotherapeutics (NWBO) Capital Expenditures (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Northwest Biotherapeutics | 253,653.43 | -1.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -85.75% |
| Dec 31, 2025 | 348.02% |
| Sep 30, 2025 | -33.55% |
| Jun 30, 2025 | 226.88% |
| Mar 31, 2025 | 19.23% |
| Dec 31, 2024 | -55.68% |
| Sep 30, 2024 | -66.22% |
| Jun 30, 2024 | 117.99% |
| Mar 31, 2024 | -42.82% |
| Dec 31, 2023 | -4.35% |
| Sep 30, 2023 | -65.01% |
| Jun 30, 2023 | -6.30% |
| Mar 31, 2023 | -38.29% |
| Dec 31, 2022 | 682.61% |
| Sep 30, 2022 | -32.35% |
| Jun 30, 2022 | 603.45% |
| Mar 31, 2022 | -96.27% |
| Dec 31, 2021 | -42.29% |
| Sep 30, 2021 | 78.57% |
| Jun 30, 2021 | 470.83% |